Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

4.52
Delayed Data
As of Feb 27
 +0.03 / +0.67%
Today’s Change
4.31
Today|||52-Week Range
15.95
-0.88%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +563.72% increase from the last price of 4.52.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$0.00
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.76%
 
 
 
 
 
 
Growthannually -46.03%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account